Site 51

Houston, Texas 77030

1 studies enrolling now · 2 studies all time

What they study most

Head and Neck Squamous Cell Carcinoma, Postmenopausal Symptoms

Studies at this site

• A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2) — Recruiting now
• Efficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor Symptoms and Vulvar and Vaginal Atrophy — Completed